Skip to main content

Advertisement

SpringerLink
Log in

Efficacy and Safety of Tranexamic Acid for Controlling Bleeding During Surgical Treatment of Intertrochanteric Fragility Fracture with Proximal Femoral Nail Anti-rotation: A Randomized Controlled Trial

  • Original Article
  • Published:
Indian Journal of Orthopaedics Aims and scope Submit manuscript

Abstract

Background

Intertrochanteric fragility fracture (IFF) treated with proximal femoral nail anti-rotation (PFNA) is associated with significant hidden blood loss and high blood transfusion rate. The purpose of the present study was to evaluate the efficacy and safety of tranexamic acid (TXA) in reducing blood loss in these patients.

Materials and Methods

Consecutive eligible patients were recruited and randomly assigned to a TXA group or a control group. The TXA group received 15 mg/kg body weight of TXA intravenously 15 min before incision and the same dose 3 h later. The control group received 100 mL of saline intravenously 15 min before incision. The efficacy outcomes included the total perioperative blood loss, postoperative transfusion rate, postoperative hemoglobin level, and length of the hospital stay. The safety outcomes were the incidence of thrombotic events and the mortality rate within 6 weeks after surgery.

Results

We had 44 patients in the TXA group and 46 patients in the control group for the final analysis. The TXA group had significantly lower total perioperative blood loss than the control group (384.5 ± 366.3 mL vs. 566.2 ± 361.5 mL; P < 0.020). Postoperative transfusion rate was 15.9% in the TXA group versus 36.9% in the control group (P = 0.024). Each group had one patient with postoperative deep venous thrombosis. In the control group, three patients had cerebral infarction, and one patient died within 6 weeks after the operation.

Conclusion

Intravenous TXA is effective in reducing total perioperative blood loss and transfusion rate in IFF treated with PFNA. No increased risk of thrombotic events was observed with the use of TXA; however, this study was underpowered for detecting this outcome. Further research is necessary before TXA can be recommended for high-risk patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wei J, Wang J, Gao M, Wang M. Analysis of perioperative blood loss in treatment of senile hip fractures. Chin J Orthop Trauma 2015;17:104–7.

    Google Scholar 

  2. Hou GJ, Zhou F, Zhang ZS, Ji HQ, Tian Y. Analysis of the blood loss in perioperative period of femoral intertrochanteric fractures in old patients treated with different internal fixations. Beijing Da Xue Xue Bao Yi Xue Ban 2013;45:738–41.

    PubMed  Google Scholar 

  3. Foss NB, Kehlet H. Hidden blood loss after surgery for hip fracture. J Bone Joint Surg Br 2006;88:1053–9.

    Article  CAS  PubMed  Google Scholar 

  4. Millar NL, Deakin AH, Millar LL, Kinnimonth AW, Picard F. Blood loss following total knee replacement in the morbidly obese: Effects of computer navigation. Knee 2011;18:108–12.

    Article  PubMed  Google Scholar 

  5. Smith GH, Tsang J, Molyneux SG, White TO. The hidden blood loss after hip fracture. Injury 2011;42:133–5.

    Article  CAS  PubMed  Google Scholar 

  6. Bao N, Zhou L, Cong Y, Guo T, Fan W, Chang Z, et al. Free fatty acids are responsible for the hidden blood loss in total hip and knee arthroplasty. Med Hypotheses 2013;81:104–7.

    Article  CAS  PubMed  Google Scholar 

  7. Piovella F, Wang CJ, Lu H, Lee K, Lee LH, Lee WC, et al. Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography. J Thromb Haemost 2005;3:2664–70.

    Article  CAS  PubMed  Google Scholar 

  8. Lee SY, Ro du H, Chung CY, Lee KM, Kwon SS, Sung KH, et al. Incidence of deep vein thrombosis after major lower limb orthopedic surgery: Analysis of a nationwide claim registry. Yonsei Med J 2015;56:139–45.

    Article  PubMed  Google Scholar 

  9. Zhou XD, Tao LJ, Li J, Wu LD. Do we really need tranexamic acid in total hip arthroplasty? A meta-analysis of nineteen randomized controlled trials. Arch Orthop Trauma Surg 2013;133:1017–27.

    Article  PubMed  Google Scholar 

  10. Wu Q, Zhang HA, Liu SL, Meng T, Zhou X, Wang P, et al. Is tranexamic acid clinically effective and safe to prevent blood loss in total knee arthroplasty? A meta-analysis of 34 randomized controlled trials. Eur J Orthop Surg Traumatol 2015;25:525–41.

    Article  PubMed  Google Scholar 

  11. Sukeik M, Alshryda S, Haddad FS, Mason JM. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br 2011;93:39–46.

    Article  CAS  PubMed  Google Scholar 

  12. Zufferey PJ, Miquet M, Quenet S, Martin P, Adam P, Albaladejo P, et al. Tranexamic acid in hip fracture surgery: A randomized controlled trial. Br J Anaesth 2010;104:23–30.

    Article  CAS  PubMed  Google Scholar 

  13. Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery 1962;51:224–32.

    PubMed  Google Scholar 

  14. Gross JB. Estimating allowable blood loss: Corrected for dilution. Anesthesiology 1983;58:277–80.

    Article  CAS  PubMed  Google Scholar 

  15. Roberts KC, Brox WT, Jevsevar DS, Sevarino K. Management of hip fractures in the elderly. J Am Acad Orthop Surg 2015;23:131–7.

    Article  PubMed  Google Scholar 

  16. Ng W, Jerath A, Wąsowicz M. Tranexamic acid: A clinical review. Anaesthesiol Intensive Ther 2015;47:339–50.

    Article  PubMed  Google Scholar 

  17. Jennings JD, Solarz MK, Haydel C. Application of tranexamic acid in trauma and orthopedic surgery. Orthop Clin North Am 2016;47:137–43.

    Article  PubMed  Google Scholar 

  18. Tang P, Hu F, Shen J, Zhang L, Zhang L. Proximal femoral nail antirotation versus hemiarthroplasty: A study for the treatment of intertrochanteric fractures. Injury 2012;43:876–81.

    Article  PubMed  Google Scholar 

  19. Mohib Y, Rashid RH, Ali M, Zubairi AJ, Umer M. Does tranexamic acid reduce blood transfusion following surgery for inter-trochanteric fracture? A randomized control trial. J Pak Med Assoc 2015;65:S17–20.

    PubMed  Google Scholar 

  20. Vijay BS, Bedi V, Mitra S, Das B. Role of tranexamic acid in reducing postoperative blood loss and transfusion requirement in patients undergoing hip and femoral surgeries. Saudi J Anaesth 2013;7:29–32.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Sadeghi M, Mehr-Aein A. Does a single bolus dose of tranexamic acid reduce blood loss and transfusion requirements during hip fracture surgery? A prospective randomized double blind study in 67 patients. Acta Med Iran 2007;45:437–42.

    CAS  Google Scholar 

  22. Tengberg PT, Foss NB, Palm H, Kallemose T, Troelsen A. Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: Results of a randomised controlled trial. Bone Joint J 2016;98-B: 747–53.

    Article  CAS  PubMed  Google Scholar 

  23. Farrow LS, Smith TO, Ashcroft GP, Myint PK. A systematic review of tranexamic acid in hip fracture surgery. Br J Clin Pharmacol 2016;82:1458–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Jimenez JJ, Iribarren JL, Lorente L, Rodriguez JM, Hernandez D, Nassar I, et al. Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: A case control study followed by a randomized double-blind controlled trial. Crit Care 2007;11:R117.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Gillette BP, Maradit Kremers H, Duncan CM, Smith HM, Trousdale RT, Pagnano MW, et al. Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. J Arthroplasty 2013;28:137–9.

    Article  PubMed  Google Scholar 

  26. Irisson E, Hémon Y, Pauly V, Parratte S, Argenson JN, Kerbaul F, et al. Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. Orthop Traumatol Surg Res 2012;98:477–83.

    Article  CAS  PubMed  Google Scholar 

  27. Gillette BP, DeSimone LJ, Trousdale RT, Pagnano MW, Sierra RJ. Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty. Clin Orthop Relat Res 2013;471:150–4.

    Article  PubMed  Google Scholar 

  28. Wu YG, Zeng Y, Yang TM, Si HB, Cao F, Shen B, et al. The efficacy and safety of combination of intravenous and topical tranexamic acid in revision hip arthroplasty: A Randomized, controlled trial. J Arthroplasty 2016;31:2548–53.

    Article  PubMed  Google Scholar 

  29. Formby PM, Pickett AM, Van Blarcum GS, Mack AW, Newman MT. The use of intravenous tranexamic acid in patients undergoing total hip or knee arthroplasty: A retrospective analysis at a single military institution. Mil Med 2015;180:1087–90.

    Article  PubMed  Google Scholar 

  30. Whiting DR, Gillette BP, Duncan C, Smith H, Pagnano MW, Sierra RJ, et al. Preliminary results suggest tranexamic acid is safe and effective in arthroplasty patients with severe comorbidities. Clin Orthop Relat Res 2014;472:66–72.

    Article  PubMed  Google Scholar 

  31. Roberts I, Perel P, Prieto-Merino D, Shakur H, Coats T, Hunt BJ, et al. Effect of tranexamic acid on mortality in patients with traumatic bleeding: Prespecified analysis of data from randomised controlled trial. BMJ 2012;345:e5839.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopaedic, People’s Hospital of Leiyang, Hunan, China

    Shunqing He, Zhian Li & Chao Huang

  2. Department of Orthopaedic, Zhujiang Hospital, Southern Medical University, Guangzhou, China

    Xiangping Luo, Zhaowei Lin &  Qi Li

Authors
  1. Xiangping Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shunqing He
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhaowei Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhian Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chao Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Qi Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qi Li.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Luo, X., He, S., Lin, Z. et al. Efficacy and Safety of Tranexamic Acid for Controlling Bleeding During Surgical Treatment of Intertrochanteric Fragility Fracture with Proximal Femoral Nail Anti-rotation: A Randomized Controlled Trial. JOIO 53, 263–269 (2019). https://doi.org/10.4103/ortho.IJOrtho_401_17

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ortho.IJOrtho_401_17

Keywords

Search

Navigation